Key result
SCN5A R1629Q mutation causes loss-of-function by shifting channel inactivation by ~21 mV.
Why the study?
Some SCN5A mutations related to Brugada syndrome have been identified in the voltage sensor of Nav1.5, but the electrophysiological characteristics of the R1629Q mutation were not described.
Does the R1629Q mutation alter the electrophysiological characteristics of the Nav1.5 channel compared to wild-type?
Does the R1629Q mutation alter the electrophysiological characteristics of the Nav1.5 channel compared to wild-type?
The R1629Q mutation in SCN5A causes a distinct loss-of-function of the Nav1.5 channel, providing biophysical insights into its association with Brugada syndrome.
R1629Q expands SCN5A variant spectrum in BrS; leaves open functional validation and screening utility.
Brugada syndrome (BrS) is an inherited arrhythmogenic syndrome leading to sudden cardiac death, partially associated with autosomal dominant mutations in SCN5A, which encodes the cardiac sodium channel alpha-subunit (Nav1.5). To date some SCN5A mutations related with BrS have been identified in voltage sensor of Nav1.5. Here, we describe a dominant missense mutation (R1629Q) localized in the fourth segment of domain IV region (DIV-S4) in a Chinese Han family. The mutation was identified by direct sequencing of SCN5A from the proband's DNA. Co-expression of Wild-type (WT) or R1629Q Nav1.5 channel and hβ1 subunit were achieved in human embryonic kidney cells by transient transfection. Sodium currents were recorded using whole cell patch-clamp protocols. No significant changes between WT and R1629Q currents were observed in current density or steady-state activation. However, hyperpolarized shift of steady-state inactivation curve was identified in cells expressing R1629Q channel (WT: V1/2 = -81.1 ± 1.3 mV, n = 13; R1629Q: V1/2 = -101.7 ± 1.2 mV, n = 18). Moreover, R1629Q channel showed enhanced intermediate inactivation and prolonged recovery time from inactivation. In summary, this study reveals that R1629Q mutation causes a distinct loss-of-function of the channel due to alter its electrophysiological characteristics, and facilitates our understanding of biophysical mechanisms of BrS.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2013) studied Brugada syndrome (n=9). SCN5A R1629Q mutation vs. Wild-type (WT) SCN5A was evaluated on Steady-state inactivation curve (V1/2) in mV (p=<0.01). The SCN5A R1629Q mutation caused a hyperpolarized shift in the steady-state inactivation curve compared to wild-type channels (-101.7 mV vs -81.1 mV, p<0.01), leading to a loss-of-function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: